Logo image of OOMA

OOMA INC (OOMA) Stock Fundamental Analysis

USA - NYSE:OOMA - US6834161019 - Common Stock

13.08 USD
+0.03 (+0.23%)
Last: 9/18/2025, 4:15:00 PM
13.08 USD
0 (0%)
After Hours: 9/18/2025, 4:15:00 PM
Fundamental Rating

4

Overall OOMA gets a fundamental rating of 4 out of 10. We evaluated OOMA against 280 industry peers in the Software industry. The financial health of OOMA is average, but there are quite some concerns on its profitability. OOMA scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

OOMA had positive earnings in the past year.
OOMA had a positive operating cash flow in the past year.
In the past 5 years OOMA always reported negative net income.
OOMA had a positive operating cash flow in each of the past 5 years.
OOMA Yearly Net Income VS EBIT VS OCF VS FCFOOMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

With a Return On Assets value of -3.30%, OOMA perfoms like the industry average, outperforming 49.29% of the companies in the same industry.
OOMA has a Return On Equity (-5.59%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -3.3%
ROE -5.59%
ROIC N/A
ROA(3y)-2.66%
ROA(5y)-2.46%
ROE(3y)-5.01%
ROE(5y)-4.92%
ROIC(3y)N/A
ROIC(5y)N/A
OOMA Yearly ROA, ROE, ROICOOMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

1.3 Margins

Looking at the Gross Margin, with a value of 60.96%, OOMA is doing worse than 61.79% of the companies in the same industry.
OOMA's Gross Margin has been stable in the last couple of years.
OOMA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y0.08%
OOMA Yearly Profit, Operating, Gross MarginsOOMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

5

2. Health

2.1 Basic Checks

OOMA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OOMA has been increased compared to 1 year ago.
Compared to 5 years ago, OOMA has more shares outstanding
OOMA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OOMA Yearly Shares OutstandingOOMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
OOMA Yearly Total Debt VS Total AssetsOOMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

An Altman-Z score of 3.93 indicates that OOMA is not in any danger for bankruptcy at the moment.
The Altman-Z score of OOMA (3.93) is better than 64.29% of its industry peers.
There is no outstanding debt for OOMA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.93
ROIC/WACCN/A
WACC10.99%
OOMA Yearly LT Debt VS Equity VS FCFOOMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.16 indicates that OOMA should not have too much problems paying its short term obligations.
The Current ratio of OOMA (1.16) is worse than 65.00% of its industry peers.
A Quick Ratio of 0.88 indicates that OOMA may have some problems paying its short term obligations.
OOMA's Quick ratio of 0.88 is on the low side compared to the rest of the industry. OOMA is outperformed by 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.88
OOMA Yearly Current Assets VS Current LiabilitesOOMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

6

3. Growth

3.1 Past

OOMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.11%, which is quite impressive.
OOMA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.25% yearly.
OOMA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.50%.
Measured over the past years, OOMA shows a quite strong growth in Revenue. The Revenue has been growing by 11.12% on average per year.
EPS 1Y (TTM)42.11%
EPS 3Y10.25%
EPS 5YN/A
EPS Q2Q%53.33%
Revenue 1Y (TTM)8.5%
Revenue growth 3Y10.13%
Revenue growth 5Y11.12%
Sales Q2Q%3.49%

3.2 Future

OOMA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.41% yearly.
OOMA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.53% yearly.
EPS Next Y22.34%
EPS Next 2Y18.42%
EPS Next 3Y28.08%
EPS Next 5Y26.41%
Revenue Next Year4.53%
Revenue Next 2Y5.11%
Revenue Next 3Y5.36%
Revenue Next 5Y6.53%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OOMA Yearly Revenue VS EstimatesOOMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
OOMA Yearly EPS VS EstimatesOOMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.15, which indicates a correct valuation of OOMA.
Based on the Price/Earnings ratio, OOMA is valued cheaply inside the industry as 83.21% of the companies are valued more expensively.
OOMA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
A Price/Forward Earnings ratio of 13.92 indicates a correct valuation of OOMA.
OOMA's Price/Forward Earnings ratio is rather cheap when compared to the industry. OOMA is cheaper than 87.14% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of OOMA to the average of the S&P500 Index (22.70), we can say OOMA is valued slightly cheaper.
Industry RankSector Rank
PE 16.15
Fwd PE 13.92
OOMA Price Earnings VS Forward Price EarningsOOMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OOMA is valued a bit cheaper than 70.71% of the companies in the same industry.
85.36% of the companies in the same industry are more expensive than OOMA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.61
EV/EBITDA 35.92
OOMA Per share dataOOMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

OOMA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OOMA's earnings are expected to grow with 28.08% in the coming years.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y18.42%
EPS Next 3Y28.08%

0

5. Dividend

5.1 Amount

OOMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OOMA INC

NYSE:OOMA (9/18/2025, 4:15:00 PM)

After market: 13.08 0 (0%)

13.08

+0.03 (+0.23%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-26 2025-08-26/amc
Earnings (Next)12-02 2025-12-02/amc
Inst Owners72.52%
Inst Owner Change0.09%
Ins Owners6.52%
Ins Owner Change-2.6%
Market Cap361.01M
Analysts81.67
Price Target18.23 (39.37%)
Short Float %2.71%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.84%
Min EPS beat(2)8.07%
Max EPS beat(2)29.6%
EPS beat(4)4
Avg EPS beat(4)13.42%
Min EPS beat(4)7.43%
Max EPS beat(4)29.6%
EPS beat(8)6
Avg EPS beat(8)9.58%
EPS beat(12)10
Avg EPS beat(12)11.46%
EPS beat(16)14
Avg EPS beat(16)17.02%
Revenue beat(2)0
Avg Revenue beat(2)-1.5%
Min Revenue beat(2)-1.65%
Max Revenue beat(2)-1.36%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-1.65%
Max Revenue beat(4)0.24%
Revenue beat(8)1
Avg Revenue beat(8)-1.34%
Revenue beat(12)2
Avg Revenue beat(12)-1.26%
Revenue beat(16)3
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)-0.14%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.08%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 16.15
Fwd PE 13.92
P/S 1.39
P/FCF 17.61
P/OCF 13.51
P/B 4.12
P/tB 8.23
EV/EBITDA 35.92
EPS(TTM)0.81
EY6.19%
EPS(NY)0.94
Fwd EY7.18%
FCF(TTM)0.74
FCFY5.68%
OCF(TTM)0.97
OCFY7.4%
SpS9.4
BVpS3.18
TBVpS1.59
PEG (NY)0.72
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.3%
ROE -5.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.96%
FCFM 7.9%
ROA(3y)-2.66%
ROA(5y)-2.46%
ROE(3y)-5.01%
ROE(5y)-4.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y0.08%
F-Score6
Asset Turnover1.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.21%
Cap/Sales 2.4%
Interest Coverage N/A
Cash Conversion 281.37%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.88
Altman-Z 3.93
F-Score6
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)63.69%
Cap/Depr(5y)72.34%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.11%
EPS 3Y10.25%
EPS 5YN/A
EPS Q2Q%53.33%
EPS Next Y22.34%
EPS Next 2Y18.42%
EPS Next 3Y28.08%
EPS Next 5Y26.41%
Revenue 1Y (TTM)8.5%
Revenue growth 3Y10.13%
Revenue growth 5Y11.12%
Sales Q2Q%3.49%
Revenue Next Year4.53%
Revenue Next 2Y5.11%
Revenue Next 3Y5.36%
Revenue Next 5Y6.53%
EBIT growth 1Y30.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year57.09%
EBIT Next 3Y35.38%
EBIT Next 5Y29.47%
FCF growth 1Y398.88%
FCF growth 3Y101.61%
FCF growth 5YN/A
OCF growth 1Y189.53%
OCF growth 3Y58.67%
OCF growth 5YN/A